Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:59 AM
Ignite Modification Date:
2025-12-25 @ 4:59 AM
NCT ID:
NCT04220918
Eligibility Criteria:
Inclusion Criteria:
* Children age 3 to 12
* Child being treated in Children's Hospital of Philadelphia
* Being prescribed clindamycin liquid
* Parental/guardian permission (informed consent) and if appropriate, child assent
* Parent age 18 or older, or a minor permitted by state law to consent for their own participation and for the participation of their child
* Parent must have primary responsibility for the patient including biologic parents and adoptive parents (if legally allowed to consent to research)
* Parent must be English speaking and able to understand study materials
Exclusion Criteria:
* Unwilling or unable to produce saliva sample
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
3 Years
Maximum Age:
12 Years
Study:
NCT04220918
Study Brief:
Protocol Section:
NCT04220918